Isolation and partial characterization of a human alveolar macrophage-derived neutrophil-activating factor.
暂无分享,去创建一个
[1] F. Brodsky,et al. Monoclonal antimacrophage antibodies: human pulmonary macrophages express HLA-DR (Ia-like) antigens in culture. , 2015, The American review of respiratory disease.
[2] R. Crystal,et al. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. , 1984, The Journal of clinical investigation.
[3] Hunninghake Gw. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. , 1984 .
[4] E. Corey,et al. Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product. , 1984, The Journal of biological chemistry.
[5] G. Toews,et al. The accessory cell function of human alveolar macrophages in specific T cell proliferation. , 1984, Journal of immunology.
[6] J. Pennington,et al. The effect of human alveolar macrophages on the bactericidal capacity of neutrophils. , 1983, The Journal of infectious diseases.
[7] W. J. Matthews,et al. Complement biosynthesis by human bronchoalveolar macrophages. , 1983, Clinical immunology and immunopathology.
[8] N. Pawlowski,et al. Human alveolar macrophages produce leukotriene B4. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[9] G. Weissmann,et al. Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis. , 1982, Biochemical and biophysical research communications.
[10] J. Salmon,et al. A radioimmunoassay for leukotriene B4. , 1982, Prostaglandins.
[11] H. Colten,et al. Biosynthesis and processing of a human precursor complement protein, pro-C3, in a hepatoma-derived cell line. , 1982, Science.
[12] J. Pennington,et al. Influence of immunosuppression on alveolar macrophage chemotactic activities in guinea pigs. , 1981, The American review of respiratory disease.
[13] E. Corey,et al. Leukotriene B. Total synthesis and assignment of stereochemistry , 1980 .
[14] E. Corey,et al. Total Synthesis of 6-Trans, 10-cis and (plus or minus) -6-Trans,8-cis Isomers of Leukotriene B , 1980 .
[15] R. Crystal,et al. Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. , 1980, The Journal of clinical investigation.
[16] D. V. Van Epps,et al. Enhancement of neutrophils function as a result of prior exposure to chemotactic factor. , 1980, The Journal of clinical investigation.
[17] R. Matthay,et al. Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization. , 1980, The Journal of clinical investigation.
[18] V. Ferrans,et al. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. , 1979, The American journal of pathology.
[19] W. Henderson,et al. Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen. , 1979, The Journal of clinical investigation.
[20] J. Pennington,et al. Evaluation of a new polyvalent Pseudomonas vaccine in respiratory infections , 1979, Infection and immunity.
[21] M. Frank. The complement system in host defense and inflammation. , 1979, Reviews of infectious diseases.
[22] A. Issekutz,et al. Enhancement of Human Neutrophil Bactericidal Activity by Chemotactic Factors , 1979, Infection and immunity.
[23] L. Simchowitz,et al. Generation of superoxide radicals by human peripheral neutrophils activated by chemotactic factor. Evidence for the role of calcium. , 1979, The Journal of laboratory and clinical medicine.
[24] J. Pennington,et al. Pathogenesis of Pseudomonas aeruginosa pneumonia during immunosuppression. , 1978, The Journal of infectious diseases.
[25] D. Roos,et al. Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes. , 1975, The Journal of laboratory and clinical medicine.
[26] J. Pennington,et al. Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. , 1974, The Journal of clinical investigation.
[27] E. Goldstein,et al. Pulmonary alveolar macrophage. Defender against bacterial infection of the lung. , 1974, The Journal of clinical investigation.
[28] B. Babior,et al. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. , 1973, The Journal of clinical investigation.
[29] S. Zigmond,et al. LEUKOCYTE LOCOMOTION AND CHEMOTAXIS , 1973, The Journal of experimental medicine.
[30] E. Wiener,et al. THE PARTICULATE HYDROLASES OF MACROPHAGES , 1963, The Journal of experimental medicine.
[31] L. Warren,et al. The thiobarbituric acid assay of sialic acids. , 1959, The Journal of biological chemistry.
[32] W. Henderson,et al. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. , 1984, The American review of respiratory disease.
[33] G. Hunninghake. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. , 1984, The American review of respiratory disease.
[34] C. Fanta,et al. Fever and new lung infiltrates in the immunocompromised host. , 1981, Clinics in chest medicine.
[35] H. B. Kaltreider. Expression of immune mechanisms in the lung. , 1976, The American review of respiratory disease.
[36] A. Bøyum,et al. Isolation of mononuclear cells and granulocytes from human blood. , 1968 .
[37] O OUCHTERLONY,et al. Diffusion-in-gel methods for immunological analysis. , 1958, Progress in allergy.